Vaccine Appears to 'Mop Up' Leukemia Cells Gleevec Leaves Behind, Johns Hopkins Kimmel Cancer Center Study

Published: Jan 11, 2010

Bookmark and Share

ScienceDaily (Jan. 10, 2010) — Johns Hopkins Kimmel Cancer Center researchers say preliminary studies show that a vaccine made with leukemia cells may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukemia (CML) patients taking the drug Imatinib mesylate (Gleevec).

Back to news